Long term follow up of topical mustine treatment for cutaneous Langerhans cell histiocytosis

Archives of Disease in Childhood

Volumn 82, Issue 6, 2000, Pages 483-487

  Hoeger, Peter H ^a   Nanduri, Vasanta R ^a   Harper, John I ^a   Atherton, David A ^a   Pritchard, Jon ^a  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

Cutaneous LCH; Long term follow up; Topical chemotherapy

Indexed keywords

CHLORMETHINE;

ARTICLE; CANCER RISK; CHILD; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HISTIOCYTOSIS X; HUMAN; MALE; PRIORITY JOURNAL; SCAR FORMATION; SKIN IRRITATION;

EID: 0034129953     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.82.6.483     Document Type: Article

References (33)

1. 1 Egeler RM, D'Angio GJ. Langerhans cell histiocytosis. J Pediatr 1995;127:1-11.
2. 2 Munn S, Chu AC. Langerhans cell histiocytosis of the skin. Hematol Oncol Clin North Am 1998;12:269-286.
3. 3 Esterly NB, Maurer HS, Gonzalez-Crussi. Histiocytosis X: a seven-year experience at a children's hospital. J Am Acad Dermatol 1985;13:481-96.
4. 4 Hoeger PH, Janka-Schaub G, Mensing H. Late manifestation of diabetes insipidus in "pure" cutaneous Langerhans cell histiocytosis. Eur J Pediatr 1997;156:524-7.
5. 5 Hancock BW, Vaughan-Hudson G, Vaughan-Hudson B, et al. British National Lymphoma Investigation randomised study of MOPP (mustine, Oncovin, procarbazine, prednisolone) against LOPP (Leukeran substituted for mustine) in advanced Hodgkin's disease - long term results. Br J Cancer 1991;63:579-82.
6. 6 Zachariae H, Thestrup-Pedersen K, Soegard H. Topical nitrogen mustard in early mycosis fungoides. Acta Derm Venereol (Stockh) 1985;65:53-8.
7. 7 Mandy S, Taylor JR, Halprin K. Topical applied mechlorethamine in the treatment of psoriasis. Arch Dermatol 1971;103:272-6.
8. 8 Zachariae H. Histiocytosis X in two infants treated with topical nitrogen mustard. Br J Dermatol 1979;100:433-8.
9. 9 Sheehan MP, Atherton DJ, Broadbent V, Pritchard J. Topical nitrogen mustard: an effective treatment for cutaneous Langerhans cell histiocytosis. J Pediatr 1991;119:317-21.
10. 10 Irving RM, Broadbent V, Jones NS. Langerhans cell histiocytosis in childhood: management of head and neck manifestations. Laryngoscope 1994;104:64-70.
11. 11 Epstein JH. Nitrogen mustard (mechlorethamine) and UVB photocarcinogenesis. A dose response effect. J Invest Dermatol 1984;83:320-2.
12. 12 du Vivier A, Vonderheid EC, van Scott EJ, Urbach F. Mycosis fungoides, nitrogen mustard and skin cancer. Br J Dermatol 1978;99:61-3.
13. 13 Kravitz PH, McDonald CJ. Topical nitrogen mustard induced carcinogenesis. Acta Dermatovener (Stockholm) 1978;58:421-5.
14. 14 Halprin KM, Comerford M, Taylor JR. Cancer in patients with psoriasis. J Am Acad Dermatol 1982;7:633-8 (correspondence: J Am Acad Dermatol 1983;9:164-5).
15. 15 Lee LA, Fritz KA, Golitz L, Fritz TJ, Weston WL. Second cutaneous malignancies in patients with mycosis fungoides treated with topical nitrogen mustard. J Am Acad Dermatol 1982;7:590-8.
16. 16 Ganor S. Skin cancer in psoriatics treated with nitrogen mustard [letter]. J Am Acad Dermatol 1983;9:164.
17. 17 Abel EA, Sendagorta E, Hoppe RT. Cutaneous malignancies and metastatic squamous cell carcinoma following topical therapies for mycosis fungoides. J Am Acad Dermatol 1986;14:1029-38.
18. 18 Vonderheid EC, Tan ET, Kantor AF, Shrager L, Micaily B, Van Scott EJ. Long-term efficiency, curative potential and carcinogenicity of topical mechlorethamine chemotherapy in cutaneous T cell lymphoma. J Am Acad Dermatol 1989; 20:416-28.
19. 19 Daughters D, Zacheim H, Maibach H. Urticaria and anaphylactoid reactions after topical application of mechlorethamine. Arch Dermatol 1973;107:429-30.
20. 20 Grunnet E. Contact urticaria and anaphylactoid reaction induced by topical application of nitrogen mustard. Br J Dermatol 1976;94:101-3.
21. 21 Goday JJ, Aguirre A, Ratón JA, Diaz-Pèrez JL. Local bullous reaction to topical mechlorethamine (mustine). Contact Dermatitis 1990;22:306-7.
22. 22 Studstrup L, Beck HI, Bjerring P, Wulf HC, Lundgren K. No detectable increase in sister chromatid exchanges in lymphocytes from mycosis fungoides patients after topical treatment with nitrogen mustard. Br J Dermatol 1988;119: 711-15.
23. 23 Nielsen M, Rasmussen K, Knudsen N, Thestrup-Pedersen K. Long-term topical nitrogen mustard treatment does not induce pulmonary fibrosis in MF patients. Acta Derm Venereol (Stockh) 1994;74:70-1.
24. 24 Writing Group of the Histiocyte Society. Histiocytosis syndromes in children. Lancet 1987;i:208-9.
25. 25 Broadbent V, Gadner H, Komp DM, Ladisch S. Histiocytosis syndromes in children: approach to the clinical and laboratory evaluation of children with Langerhans cell histiocytosis. Med Pediatr Oncol 1989;17:492-5.
26. 26 Avril MF. La caryolysine locale. Ann Dermatol Venereol 1987;114:133-41.
27. 27 Vonderheid EC. Topical mechlorethamine chemotherapy. Considerations on its use in mycosis fungoides. Int J Dermatol 1984;23:180-6.
28. 28 McLelland J, Broadbent V, Yeomans E, Malone M, Pritchard J. Langerhans cell histiocytosis: the case for conservative treatment. Arch Dis Child 1990;65:301-3.
29. 29 Whitlock JA, Greer JP, Lukens JN. Epipodophyllotoxin related leukemia. Cancer 1991;68:600-4.
30. 30 Stern RS, Nichols KT, Väkevä LH. Malignant melanoma in patients treated for psoriasis with methoxysalen (psoralen) and ultraviolet A radiation (PUVA). N Engl J Med 1997;336:1041-5.
31. 31 Taylor JR, Halprin KM. Topical use of mechlorethamine in the treatment of psoriasis. Arch Dermatol 1972;106:362-4.
32. 32 Lee CW, Park MH, Lee H. Recurrent cutaneous Langerhans cell histiocytosis in infancy. Br J Dermatol 1988;119: 259-65.
33. 33 Van Vloten WA, Gooijmanns ACM, Poel J, Meulenbelt J. Concentrations of nitrogen mustard in the air during topical treatment of patients with mycosis fungoides. Br J Dermatol 1993;128:404-6.